Phibro Animal Health Corporation (PAHC) Stock Forecast & Price Target
Phibro Animal Health Corporation · NASDAQ
$37.37-0.88 (-2.30%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Phibro Animal Health Corporation, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $44.00 to $50.00, so the covering firms are broadly aligned. The average target of $47.00 sits 26% above the current $37.37. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.97 next quarter toward $3.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Phibro Animal Health Corporation.
As of Sep, 1 of 2 firms rate PAHC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PAHC EPS & revenue forecast
EPS · NEXT QUARTER
$0.97
Range $0.92 – $1.01 · 3 analysts · +11% YoY
Next period, 3 analysts expect Phibro Animal Health Corporation to earn $0.97 a share (range $0.92 – $1.01), versus $0.87 a year earlier. Full-year consensus is $3.50, growing to $3.85 the year after.
REVENUE · NEXT QUARTER
$392.6M
Range $391.3M – $393.8M · 3 analysts · +5% YoY
Revenue is expected to reach $392.6M (range $391.3M – $393.8M), +5.0% year-over-year. Full-year consensus is $1.6B, rising to $1.6B next year.
Top analysts covering Phibro Animal Health Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PAHC.
#1
Erin Wright
Morgan Stanley · Rank #36
Hold
$49.00+31.1% to target
Overall win rate
59%
+ Follow
#2
Balaji Prasad
Barclays · Rank #178
Sell
$22.00-41.1% to target
Overall win rate
44%
+ Follow
#3
Daniel Grosslight
Citigroup
Hold
$44.00+17.7% to target
Coverage
—
+ Follow
#4
EK
Ekaterina Knyazkova
JP Morgan
Buy
$50.00+33.8% to target
Coverage
—
+ Follow
#5
NT
Navann Ty
Exane BNP Paribas
Hold
$37.00-1.0% to target
Coverage
—
+ Follow
PAHC stock forecast FAQ
What is PAHC's average 12-month price target?+
The 2 analysts with a live target average $47.00 for Phibro Animal Health Corporation over the next 12 months, ranging from a $50.00 high to a $44.00 low.
Is PAHC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PAHC?+
The Street-high target is $50.00 (JP Morgan), and the Street-low is $44.00 (Citigroup). The average of all 2 active targets is $47.00.
How many Wall Street analysts cover PAHC?+
2 analysts have an active rating on Phibro Animal Health Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering PAHC?+
Among analysts who currently cover PAHC, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #36). Their current call is Hold with a $49.00 target.
What is Phibro Animal Health Corporation's projected EPS for next quarter?+
The consensus estimate is $0.97 per share (range $0.92 – $1.01) across 3 analysts. Full-year EPS is projected at $3.50, rising to $3.85 the following year.
How much revenue is Phibro Animal Health Corporation expected to report next quarter?+
Consensus revenue is $392.6M (range $391.3M – $393.8M). Full-year revenue is projected at $1.6B, growing to $1.6B next year.
Have analysts been upgrading or downgrading PAHC lately?+
As of Sep, 1 of 2 firms rate PAHC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PAHC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
